Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BioPharm International is Scopus-indexed (Q4, CiteScore 0.4), WoS SCIE. Published by Advanstar Communications Inc..
Checked against the index lists dated .
ISSN 1542-166XVerify ISSN ↗1939-1862Verify ISSN ↗
Publisher: Advanstar Communications Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 165 / 191 | 13th | Q4 |
| Biotechnology | 310 / 325 | 4th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q4, CiteScore 0.4.
BioPharm International is Q4 in Pharmaceutical Science (rank 165 of 191) and Q4 in Biotechnology (rank 310 of 325), by CiteScore 2025.
BioPharm International is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.4, which places it in quartile Q4 at the 13th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.111, quartile Q4, with an H-index of 33.
BioPharm International is published by Advanstar Communications Inc. Its print ISSN is 1542-166X and its online ISSN is 1939-1862.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
BioPharm International has an h-index of 7 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 0.4, quartile Q4. On 2-year citations it ranks #162 of 177 Scopus journals in Pharmaceutical Science.
BioPharm International published 3 papers in 2020; its busiest recent year was 2009 with 4. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.